Page 142 - J7107_anmco25_Progr_def_V18

SESSIONI e-POSTER

GIOVEDÌ 15 MAGGIO

16.00-17.00 - SALA della PIAZZA

PREVENZIONE - TERAPIA Pannello B
(S 2281)

Moderatore: Andrea Di Girolamo (Guastalla)

P7 - HORMONAL THERAPY-INDUCED SEVERE DYSLIPIDEMIA
V. Altamura,-S. Di Fusco,-G. Marino,-F. Colivicchi
P.O. San Filippo Neri - Asl Roma 1, Roma; P.O. San Filippo Neri - Asl Roma 1, Roma; Po San Filippo Neri, Asl Roma 1, Roma;
P.O. San Filippo Neri - Asl Roma 1, Roma

P8 P- LEIOTROPIC EFFECTS OF INCLISIRAN ON ARTERIAL STRUCTURAL AND FUNCTIONAL
PARAMETERS
M. Bellomare,-G. Toscani,-C. Tognola,-A. Shkodra,-M. Algeri,-S. Fabbri,-R. Pirola,-I. Garofani,
F. Politi,-C. Giannattasio,-A. Maloberti
Università degli studi di Milano-Bicocca, Dipartimento di Medicina e Chirurgia, Milano; Asst Ospedale Metropolitano Niguarda,
Milano; Università degli studi di Milano-Bicocca, Dipartimento di Medicina e Chirurgia, Milano; Asst Ospedale Metropolitano
Niguarda, Milano; Asst Ospedale Metropolitano Niguarda, Milano; Asst Ospedale Metropolitano Niguarda, Milano;
Asst Ospedale Metropolitano Niguarda, Milano; Asst Grande Ospedale Metropolitano Niguarda, Milano; Asst Ospedale
Metropolitano Niguarda, Milano

P9 - EVALUATING DYSLIPIDAEMIA TREATMENT WITH BEMPEDOIC ACID AND EZETIMIBE
OVER 8 WEEKS IN THE ITALIAN COHORT OF THE MILOS OBSERVATIONAL STUDY
M. Averna,-I. Gouni-berthold,-J. Jukema,-J. E Roeters Van Lennep,-K. Ray,-K. Koskinas,-T. Stulnig,-
T. Vanassche,-M. Lamparter,-K. Wenz-pöschl,-R. Chhabra,-R. Gambacurta,-M. De Muniateguj
Climente,-X. Pintó,-K. Parhofer
Center for Endocrinology, Diabetes and Preventive Medicine, University of Cologne, Faculty of Medicine and University Hospital
Cologne, Cologne, Germany, Cologne; Department of Cardiology, Leiden University Medical Center, Leiden, Netherlands, Leiden;
Department of Internal Medicine, Cardiovascular Institute, Erasmus Medical Center, Rotterdam, The Netherlands;, Rotterdam;
Imperial Centre for Cardiovascular disease Prevention, Ictu-global, Imperial College London, London, UK, London; Bern University
Hospital, Bern, Switzerland, Bern; Department of Medicine and Karl Landsteiner Institute For Metabolic diseases and Nephrology,
Clinic Hietzing, Vienna, Austria, Vienna; Daiichi Sankyo Europe Gmbh, Munich, Germany, Munich; Daiichi Sankyo Europe Gmbh,
Munich, Germany, Munich; Daiichi Sankyo Europe Gmbh, Munich, Germany, Munich; Daiichi Sankyo Europe Gmbh, Rome, Italy,
Rome; Daiichi Sankyo Spain, Barcelona, Spain, Barcelona; Department of Internal Medicine, Hospital Universitari De Bellvitge-
idibell-ub-ciberobn, Barcelona, Spain, Barcelona; Ludwig-maximilians University Munich, Lmu-klinikum Medical Department 4 –
Grosshadern, Munich, Germany

P10 - EARLY USE OF TRIPLE LIPID LOWERING THERAPY IN ACS PATIENTS IN DIFFERENT
HOSPITALS
B. Demichelis,-F. Delnevo,-R. Fasano,-I. Radano,-C. De Rosa,-S. Muccioli,-G. Annibali,-
A. Ricotti,-A. Riba,-R. D’Aniello,-M. Ferrua Trucco,-L. Coda,-L. Gaido,-M. Giammaria,-G. Musumeci
Ospedale Maria Vittoria, Torino; Ospedale Mauriziano Umberto I, Torino; Ospedale Maria Vittoria, Torino; Ospedale Mauriziano
Umberto I, Torino; Ospedale Mauriziano Umberto I, Torino; Ospedale Mauriziano Umberto I, Torino; Ospedale Mauriziano
Umberto I, Torino; Ospedale Mauriziano Umberto I, Torino; Ospedale Mauriziano Umberto I, Torino; Ospedale Mauriziano
Umberto I, Torino; Ospedale Maria Vittoria, Torino; Ospedale Martini, Torino; Ospedale Maria Vittoria, Torino; Ospedale
Mauriziano Umberto I, Torino

142